These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 12374681

  • 1. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 2. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 3. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2002 Aug 01; 8(8):2553-62. PubMed ID: 12171883
    [Abstract] [Full Text] [Related]

  • 4. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Aug 01; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 5. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL.
    Clin Cancer Res; 2001 Mar 01; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [Abstract] [Full Text] [Related]

  • 6. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 7. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Sep 01; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 8. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S, Koike N, Adachi S.
    J Cancer Res Clin Oncol; 2002 Feb 01; 128(2):73-9. PubMed ID: 11862476
    [Abstract] [Full Text] [Related]

  • 9. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 10. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM, Pandeya N, Cummings MC, Walsh MD, Young JP, Leggett BA, Purdie DM, Jass JR, Radford-Smith GL.
    J Pathol; 2003 Sep 01; 201(1):46-54. PubMed ID: 12950016
    [Abstract] [Full Text] [Related]

  • 11. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
    Taylor DD, Gerçel-Taylor C, Lyons KS, Stanson J, Whiteside TL.
    Clin Cancer Res; 2003 Nov 01; 9(14):5113-9. PubMed ID: 14613988
    [Abstract] [Full Text] [Related]

  • 12. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
    Müller D, Lang S, Roskrow M, Wollenberg B.
    Laryngorhinootologie; 2002 Jul 01; 81(7):516-20. PubMed ID: 12173063
    [Abstract] [Full Text] [Related]

  • 13. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 01; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 14. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL.
    Clin Cancer Res; 1996 Jan 01; 2(1):161-73. PubMed ID: 9816103
    [Abstract] [Full Text] [Related]

  • 15. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
    Reichert TE, Day R, Wagner EM, Whiteside TL.
    Cancer Res; 1998 Dec 01; 58(23):5344-7. PubMed ID: 9850063
    [Abstract] [Full Text] [Related]

  • 16. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 17. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U, Rindsfüser M, Grussenmeyer T, Schultze-Seemann W, Wetterauer U.
    Br J Cancer; 2000 Sep 01; 83(5):637-41. PubMed ID: 10944605
    [Abstract] [Full Text] [Related]

  • 18. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
    Kono K, Ressing ME, Brandt RM, Melief CJ, Potkul RK, Andersson B, Petersson M, Kast WM, Kiessling R.
    Clin Cancer Res; 1996 Nov 01; 2(11):1825-8. PubMed ID: 9816136
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
    Kuss I, Saito T, Johnson JT, Whiteside TL.
    Clin Cancer Res; 1999 Feb 01; 5(2):329-34. PubMed ID: 10037182
    [Abstract] [Full Text] [Related]

  • 20. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
    Liu Y, Poon RT, Feng X, Yu WC, Luk JM, Fan ST.
    Am J Gastroenterol; 2004 Jun 01; 99(6):1111-21. PubMed ID: 15180734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.